Regenerative Medicine and Skeleton, Inserm u1229 RMeS Company Profile, Contacts & Intelligence

Regenerative Medicine and Skeleton, Inserm u1229 RMeS Overview

The aim of our lab is to support basic, translational and clinical research pertinent to the 4R medicine (ie. Replace, Repair, Regenerate and Reprogram) related to skeleton diseases and aging. The skeleton diseases originates from developmental abnormalities, growth impairment, repair dysfunction, aging or acquired pathologies. Among these diseases, we are particularly interested in discovering new therapeutic strategies for osteoporosis, osteoarthritis, discarthrosis and periodontitis. Due to the increasing clinical situations where skeletal tissues are lost or compromised (bone, cartilage, teeth, disc..) we also focuse our research efforts on the use of stem cells, calcium phosphate ceramics and hydrogels for the development of reconstructive therapeutics. By formalizing an interdisciplinary approach, and providing researchers with a functional organizational structure, RMeS aims at offering a strong support and stimulating environment for exploring the limit of knowledge in 4R medicine.

Headquarters

Nantes, Loire-atlantique, Fr

Website

rmes.univ-nantes.fr

Industry

Biotechnology Research

Founded

2022

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Regenerative Medicine and Skeleton, Inserm u1229 RMeS Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Regenerative Medicine and Skeleton, Inserm u1229 RMeS People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Regenerative Medicine and Skeleton, Inserm u1229 RMeS Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Regenerative Medicine and Skeleton, Inserm u1229 RMeS

Explore companies in related markets and compare their industry and employee estimates.